miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan
Journal article published in 2014 by
J. Schou,
S. Rossi,
B. Jensen,
D. L. Nielsen,
P. Pfeiffer,
E. Hogdall 
,
M. Yilmaz,
S. Tejpar,
M. Delorenzi,
M. Kruhoffer,
J. S. Johansen
,
M. Yilmaz,
S. Tejpar,
M. Delorenzi,
M. Kruhoffer,
J. S. Johansen
